Clin2
NCT07548957Worth exploringNot yet recruiting

Testing a new medicine in healthy adults

Diabetes Mellitus (Type 2)

Part of Hormones & metabolism clinical trials.

This study tests a new medication (UI087) in healthy volunteers to see how safe it is and how the body processes it, compared to taking three separate medicines together. It's an early-phase trial that may help future patients with a similar treatment option.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
44 people
Ages
19 years and older
Study type
Interventional

Who can take part

  • You are 19 years or older.
  • You weigh at least 50 kg (about 110 lbs) for men, or 45 kg (about 99 lbs) for women, and your body mass index (BMI) is between 18 and 30.
  • You are generally healthy, with no major ongoing or chronic diseases.
  • You have not used certain medications, taken part in another drug trial, or donated blood recently.
  • You agree to use approved birth control (non-hormonal) and not donate sperm or eggs during the study.
  • You are not pregnant, breastfeeding, or planning to be.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07682948Recruiting· Phase 1
Drug interaction study of UIC202601 and UIC202602 in healthy volunteers

This trial tests how two experimental drugs, UIC202601 and UIC202602, interact with each other in the body. Healthy volunteers take both drugs to check for side effects and how the body processes them.

Anyang, Manan-gu
NCT07034781Not yet recruiting· Phase 1
Study of a combination diabetes pill in healthy adults

This trial tests a combination of three diabetes medicines (dapagliflozin, linagliptin, and metformin) in healthy adults to see how safe they are and how the body processes them. Participating could help make sure these medicines are safe for people with diabetes.

Gwangmyeong, Gyeonggi-do
NCT07748702Not yet recruiting· Phase 1
Study of a new drug in healthy volunteers

This trial tests a new medicine (CKD-339) in healthy people to see how the body processes it and if it is safe. It is an early-stage study that could help develop a treatment for conditions like high blood pressure or heart problems.

Seoul
NCT07311811Not yet recruiting· Phase 1
Study of two new drugs in healthy volunteers

This study tests two investigational drugs in healthy adults to see how the body absorbs, breaks down, and eliminates them, and to check for any side effects. If you are a healthy adult, you may be able to help researchers understand these drugs better.

Seoul
NCT06635226Recruiting· Phase 1
Safety study of ID110521156 in healthy adults

This study tests a new investigational drug called ID110521156 in healthy adults. The goal is to see if the drug is safe and how the body processes it. It may be for people who are overweight or obese.

Seoul
NCT07630233Recruiting· Phase 1
Safety and effects of UBT38006 injection in healthy men

This early-stage study tests a new injectable medication (UBT38006) in healthy adult men to understand how safe it is and how the body processes it. Researchers want to make sure the injection doesn't cause serious side effects and works as expected.

Hefei, Anhui

Hear when a new Diabetes Mellitus (Type 2) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.